United States · FDA National Drug Code directory
Rizatriptan Benzoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 29300-316_b86514bb-961e-4cf9-9f52-d5f441b7c97f
- Product NDC
- 29300-316
- Form
- TABLET
- Composition / generic term
- Rizatriptan Benzoate
- Labeler
- Unichem Pharmaceuticals (USA), Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170307
- Source listing expiry
- 20261231
Source-listed ingredients
- RIZATRIPTAN BENZOATE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BLISTER PACK in 1 CARTON (29300-316-21) / 3 TABLET in 1 BLISTER PACK (29300-316-31) · 29300-316-21
- 6 BLISTER PACK in 1 CARTON (29300-316-81) / 3 TABLET in 1 BLISTER PACK (29300-316-31) · 29300-316-81
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →